Boulder Hill Capital Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,700
Closed -$980K 221
2021
Q4
$980K Buy
+3,700
New +$997K 0.95% 16

Other funds holding RGEN

Boulder Hill Capital Management's RGEN Position: Q1 2022 in Review

Boulder Hill Capital Management sold out of Repligen (RGEN) in Q1 2022, closing a stake of 3,700 shares — an estimated $980K sold.

Boulder Hill Capital Management first reported a position in RGEN in Q4 2021 and held it in 1 quarter. The position peaked at $980K in Q4 2021. 450 funds tracked by Wall St. Rank hold RGEN as of Q1 2022.

  • Boulder Hill Capital Management reported no remaining Repligen position as of Q1 2022 after selling out during the quarter.
  • Boulder Hill Capital Management sold 3,700 Repligen shares in Q1 2022, an estimated $980K.
  • Boulder Hill Capital Management first reported a position in Repligen in Q4 2021 and held it in 1 quarter.
  • Boulder Hill Capital Management's Repligen position peaked at $980K in Q4 2021.
  • 450 funds tracked by Wall St. Rank held Repligen as of Q1 2022.

Based on Boulder Hill Capital Management's 13F filing for Q1 2022, filed 12 May 2022.